Correlation Between Bluejay Diagnostics and Bone Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bluejay Diagnostics and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bluejay Diagnostics and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bluejay Diagnostics and Bone Biologics Corp, you can compare the effects of market volatilities on Bluejay Diagnostics and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bluejay Diagnostics with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bluejay Diagnostics and Bone Biologics.

Diversification Opportunities for Bluejay Diagnostics and Bone Biologics

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Bluejay and Bone is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Bluejay Diagnostics and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Bluejay Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bluejay Diagnostics are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Bluejay Diagnostics i.e., Bluejay Diagnostics and Bone Biologics go up and down completely randomly.

Pair Corralation between Bluejay Diagnostics and Bone Biologics

Given the investment horizon of 90 days Bluejay Diagnostics is expected to generate 3.41 times more return on investment than Bone Biologics. However, Bluejay Diagnostics is 3.41 times more volatile than Bone Biologics Corp. It trades about 0.02 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about -0.16 per unit of risk. If you would invest  530.00  in Bluejay Diagnostics on August 28, 2024 and sell it today you would lose (155.00) from holding Bluejay Diagnostics or give up 29.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bluejay Diagnostics  vs.  Bone Biologics Corp

 Performance 
       Timeline  
Bluejay Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bluejay Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Bone Biologics Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Bluejay Diagnostics and Bone Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bluejay Diagnostics and Bone Biologics

The main advantage of trading using opposite Bluejay Diagnostics and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bluejay Diagnostics position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.
The idea behind Bluejay Diagnostics and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing